Higher Serum 25(OH)D Levels Associated With Reduced Risk Of Overall Mortality, CVD In Patients With Psoriasis, Study Finds

Dermatology Advisor (6/16, Nye) reports a study found that “higher concentrations of serum 25-hydroxyvitamin D (25[OH]D) are associated with decreased risk for cardiovascular disease (CVD) and mortality among individuals with psoriasis.” Researchers observed that among study participants with psoriasis, the “risk for CVD was lower among individuals with intermediate and high serum 25(OH)D levels compared with those with low levels. For every standard deviation increase in serum 25(OH)D the risk for CVD decreased. Compared with low serum 25(OH)D levels, the risk of mortality was significantly lower among individuals with intermediate and high serum 25(OH)D levels (both P <.001). Similar to CVD, the risk of mortality decreased with every standard deviation increase in serum 25(OH)D.” The study was published in the Journal of the American Academy of Dermatology.